Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Nov 12:13:3855-3866.
doi: 10.2147/DDDT.S227499. eCollection 2019.

Hesperidin: A Therapeutic Agent For Obesity

Haijun Xiong  1 , Jin Wang  1 , Qian Ran  1 , Guanhua Lou  1 , Chengyi Peng  1 , Qingxia Gan  1 , Ju Hu  1 , Jilin Sun  2 , Renchuan Yao  3 , Qinwan Huang  1   4
Affiliations
Review

Hesperidin: A Therapeutic Agent For Obesity

Haijun Xiong et al. Drug Des Devel Ther. .

Abstract

Obesity is a chronic metabolic disease caused by multiple factors and is considered to be a risk factor for type 2 diabetes, cardiovascular disease, hypertension, stroke and various cancers. Hesperidin, a flavanone glycoside, is a natural phenolic compound with a wide range of biological effects. Mounting evidence has demonstrated that hesperidin possesses inhibitory effect against obesity diseases. Our review discusses mechanisms of hesperidin in the treatment of obesity. Hesperidin regulates lipid metabolism and glucose metabolism by mediating AMPK and PPAR signaling pathways, directly regulates antioxidant index and anti-apoptosis, and indirectly mediates NF-κB signaling pathway to regulate inflammation to play a role in the treatment of obesity. In addition, hesperidin-enriched dietary supplements can significantly improve symptoms such as postprandial hyperglycemia and hyperlipidemia. Further clinical trials are also required for confirming lipid-lowering efficacy of this natural flavonoid and evaluating its safety profile.

Keywords: anti-inflammatory; anti-oxidation; citrus flavonoids; glucose metabolism; lipid metabolism.

PubMed Disclaimer

Conflict of interest statement

Jilin Sun is the general manager of Sichuan Fuzheng Pharmaceutical Co. Ltd. The authors report no other conflicts of interest in this work.

Figures

Figure 1
Figure 1
Chemical structures of hesperidin (A) and hesperetin (B).
Figure 2
Figure 2
The effect of hesperidin on lipid metabolism. Note: formula imageindicate inhibition/reduction while formula image indicate increase/promotion.
Figure 3
Figure 3
The effect of hesperidin on glucose metabolism. Note: formula imageindicate inhibition/reduction while formula image indicate increase/promotion.
Figure 4
Figure 4
The effect of hesperidin on oxidation and inflammation. Note: formula imageindicate inhibition/reduction while formula image indicate increase/promotion.
See this image and copyright information in PMC

References

    1. Hall KD, Ayuketah A, Brychta R, et al. Ultra-processed diets cause excess calorie intake and weight gain: an inpatient randomized controlled trial of Ad libitum food intake. Cell Metab. 2019;30(1):67–77.e63. doi:10.1016/j.cmet.2019.05.008 - DOI - PMC - PubMed
    1. Uti DE, Atangwho IJ, Eyong EU, et al. African walnut (Tetracarpidium conophorum) modulates hepatic lipid accumulation in obesity via reciprocal actions on HMG-CoA reductase and paraoxonase. Endocr Metab Immune Disord Drug Targets. 2019. doi:10.2174/1871530319666190724114729 - DOI - PubMed
    1. Yan Q. Progress in research on the causes of obesity. Neijiang Technol. 2009;30(9):29.
    1. Depommier C, Everard A, Druart C, et al. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nat Med. 2019;25(7):1096–1103. doi:10.1038/s41591-019-0495-2 - DOI - PMC - PubMed
    1. Rossi MA, Basiri ML, McHenry JA. Obesity remodels activity and transcriptional state of a lateral hypothalamic brake on feeding. Science. 2019;364(6447):1271–1274. doi:10.1126/science.aax1184 - DOI - PMC - PubMed

MeSH terms